No. |
論文題名 |
1 |
Liver toxicity of intravenous heparin treatment in patients with acute ischemic stroke./Clin Neurol Neurosurg./13: 2023/Yasutaka Y, Fujioka S, Tsuboi Y, Oyabu K, Shibaguchi H, Kamimura H. |
2 |
Impact of non-motor fluctuations on QOL in patients with Parkinson's disease./Front Neurol./14: 2023/ Kakimoto A, Kawazoe M, Kurihara K, Mishima T, Tsuboi Y. |
3 |
Evaluation of perception threshold and pain in patients with Parkinson's disease using PainVision®/Front Neurol./5: 2023/Kurihara K, Fujioka S, Mishima T, Tsuboi Y. |
4 |
Impact of Parkinson's Disease on Caregiver Quality of Life in Japan./Mov Disord Clin Pract./14: 10(4)658-663, 2023/Nagaki K, Nakagawa R, Ishido M, Yoshinaga Y, Watanabe J, Kurihara K, Hayashi Y, Ogura H, Mishima T, Fujioka S, Tsuboi Y. |
5 |
Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST./J Neurol Sci./15: 2023/Mishima T, Chiu SW, Saiki H, Yamaguchi T, Shimo Y, Maeda T, Watanabe H, Kashihara K, Nomoto M, Hattori N, Tsuboi Y |
6 |
Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan./Front Pharmacol./12: 2023/Kainuma M, Kawakatsu S, Kim JD, Ouma S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. |
7 |
Factors that impact dysphagia and discontinuance of oral intake in patients with progressive supranuclear palsy./Front Neurol./13: 2023/Iwashita Y, Umemoto G, Fujioka S, Arahata H, Dotsu Y, Oike A, Tsuboi Y. |
8 |
Altered properties of amyloidogenic prion protein in genetic Creutzfeldt-Jakob disease with PRNP V180I mutation in response to pentosan polysulfate./Brain Pathol./33(5):e13197. 2023/Shijo M, Yoshimura M, Omae T, Hashimoto G, Mizoguchi T, Kuwashiro T, Komori T, Tsuboi Y, Saito T, Nakagawa M, Itoh K, Honda H. |
9 |
Association between physical activity and health literacy in patients with Parkinson's disease: an online web survey./BMC Neurol./23(1):403, 2023/Nagaki K, Mishima T, Ohura T, Kurihara K, Fujioka S, Tsuboi Y |
10 |
Non‐ergot dopamine agonist therapy for Parkinson's disease in Japan: A claims database analysis./Neurology and Clinical Neuroscience./11(2), 63-71. 2023/Wada‐Isoe, K., Tsuboi, Y., Kondo, H., Kojima, Y., Takeshima, T., Iwasaki, K. |
11 |
Differences in Parkinson's disease treatment between neurology and other departments in Japan./Neurology and Clinical Neuroscience/11(2), 79-89. 2023/Tsuboi, Y., Wada‐Isoe, K., Kondo, H., Kojima, Y., Takeshima, T., Iwasaki, K. |
12 |
Precision Mapping of Thalamic Deep Brain Stimulation Lead Positions Associated With the Microlesion Effect in Tourette Syndrome./Neurosurgery./93(4):875-883. 2023/Morishita T, Sakai Y, Iida H, Yoshimura S, Fujioka S, Oda K, Tanaka SC, Abe H. |